The note is the current scenario (Base). Download PDF renders this page on the server, fonts and colours exact; Print uses the browser.
Model Note · AMRUTAJAN HEALTH LTD · 11 September 2026Page 1 of 2
Model Note
Prepared by the reader · not a MarketPing document
AMRUTAJAN HEALTH LTD
Discounted cash flow · base FY26

AMRUTAJAN HEALTH LTD

Value per share, this model283
CMP 2026-09-10490.95
Difference(42.4)%
Growth the CMP implies26.4%/yr

This note states the assumptions and the arithmetic of one model of AMRUTAJAN HEALTH LTD, built on its filed FY26 consolidated statements. The value is the outcome of the assumptions below and nothing else; it is not a fair value, a target or a recommendation.

Assumptions

InputThis modelFiled reference
Revenue growth, 5 years11% a yearFY26 11.2% · 5-yr CAGR 8.6%
EBITDA margin13.3%FY26 13.3% · 5-yr average 13.9%
Depreciation · capex, % of revenue1.3% · 10.9%, fading to 1.2× depreciationFY26 1.3% · 10.9%
Working capital, % of added revenue · tax5.4% · 25.6%20 working-capital days · effective 25.6%
Discount rate11.00%1-yr beta 0.46
After FY315% flat · mid-year discounting
Net debt · non-controlling interest · non-operating investments(11) · ₹0 · ₹0 crFY26 net debt ₹(11) cr
Shares2.89 crore2.89 crore today
Source: SEBI results XBRL as filed with BSE/NSE, exchange prices; the reader's assumptions.

Projected cash flow to the firm

₹ croreFY26FY27FY28FY29FY30FY31
Revenue503558619687763847
growth %11.211.011.011.011.011.0
EBITDA67748291101113
Depreciation(6)(7)(8)(9)(10)(11)
NOPAT455055616876
less capex(55)(61)(53)(43)(30)(13)
less working-capital build(3)(3)(4)(4)(5)
Free cash flow to firm(7)7244469
Present value(6)6183143
Source: the model; base year as filed.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
Model Note · AMRUTAJAN HEALTH LTD · 11 September 2026Page 2 of 2

From enterprise to equity

PV of the 5 explicit years92
PV of the terminal value (89% of EV)715
Enterprise value807
less net debt11
less non-controlling interest0
add non-operating investments0
Equity value818
÷ 2.89 crore shares283
Source: the model.

Sensitivity, ₹ per share

WACC ↓ · terminal growth →4.0%4.5%5.0%5.5%6.0%
10.0%293318347383429
10.5%267288312341377
11.0%246263283307335
11.5%227241258278301
12.0%210223237254273
Source: the model; n/a where terminal growth reaches the discount rate.

Statement

This note is the reader's own model over publicly filed information: SEBI results XBRL filed with BSE and NSE and exchange price data, assembled by MarketPing software; every assumption above is the reader's. It contains no research recommendation, no price target and no opinion by MarketPing on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Historical per-share figures are on the current share count. Where a figure is unavailable the table shows a dash rather than an estimate. Nothing here constitutes investment advice, an offer or a solicitation.

Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in